Literature DB >> 35298721

Th17 cells and their related cytokines: vital players in progression of malignant pleural effusion.

Yiran Niu1, Qiong Zhou2.   

Abstract

Malignant pleural effusion (MPE) is an exudative effusion caused by primary or metastatic pleural carcinosis. Th17 cells and their cytokines are critical components in various disease including MPE. In this review, we summarize current published articles regarding the multifunctional roles of Th17 cells and their related cytokines in MPE. Th17 cells are accumulated in MPE compared with paired serum via certain manners. The upregulation of Th17 cells and the interactions between Th17 cells and other immune cells, such as Th1 cells, Th9 cells, regulatory T cells and B cells, are reported to be involved in the formation and development of MPE. In addition, cytokines, which are elaborated by Th17 cells, including IL-17A, IL-17F, IL-21, IL-22, IL-26, GM-CSF, or associated with Th17 cells differentiation, including IL-1β, IL-6, IL-23, TGF-β, are linked to the pathogenesis of MPE through exerting pro- or anti-tumorigenic functions on their own as well as regulating the generation and differentiation of Th17 cells in MPE. Based on these findings, we proposed that Th17 cells and their cytokines might be diagnostic or prognostic tools and potential therapeutic targets for MPE.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Cytokine; Immune cell; Malignant pleural effusion; Th17 cells; Tumor microenvironment

Mesh:

Substances:

Year:  2022        PMID: 35298721     DOI: 10.1007/s00018-022-04227-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  94 in total

Review 1.  Making cold malignant pleural effusions hot: driving novel immunotherapies.

Authors:  Pranav Murthy; Chigozirim N Ekeke; Kira L Russell; Samuel C Butler; Yue Wang; James D Luketich; Adam C Soloff; Rajeev Dhupar; Michael T Lotze
Journal:  Oncoimmunology       Date:  2019-01-22       Impact factor: 8.110

2.  Helper T cells in malignant pleural effusion.

Authors:  Feng-Shuang Yi; Kan Zhai; Huan-Zhong Shi
Journal:  Cancer Lett       Date:  2020-12-10       Impact factor: 8.679

3.  Host-derived interleukin-5 promotes adenocarcinoma-induced malignant pleural effusion.

Authors:  Georgios T Stathopoulos; Taylor P Sherrill; Sophia P Karabela; Kasia Goleniewska; Ioannis Kalomenidis; Charis Roussos; Barbara Fingleton; Fiona E Yull; R Stokes Peebles; Timothy S Blackwell
Journal:  Am J Respir Crit Care Med       Date:  2010-07-01       Impact factor: 21.405

4.  US Hospitalizations for Malignant Pleural Effusions: Data From the 2012 National Inpatient Sample.

Authors:  Niloofar Taghizadeh; Marc Fortin; Alain Tremblay
Journal:  Chest       Date:  2016-11-19       Impact factor: 9.410

5.  CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion.

Authors:  Fei Wang; Li Yang; Qun Gao; Lan Huang; Liping Wang; Jing Wang; Shengdian Wang; Bin Zhang; Yi Zhang
Journal:  Cancer Immunol Immunother       Date:  2015-05-06       Impact factor: 6.968

6.  The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer.

Authors:  Pieter E Postmus; Elisabeth Brambilla; Kari Chansky; John Crowley; Peter Goldstraw; Edward F Patz; Hiroyasu Yokomise
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

7.  Prognostic impact of minimal pleural effusion in non-small-cell lung cancer.

Authors:  Jeong-Seon Ryu; Hyo Jin Ryu; Si-Nae Lee; Azra Memon; Seul-Ki Lee; Hae-Seong Nam; Hyun-Jung Kim; Kyung-Hee Lee; Jae-Hwa Cho; Seung-Sik Hwang
Journal:  J Clin Oncol       Date:  2014-02-18       Impact factor: 44.544

8.  Mast cells mediate malignant pleural effusion formation.

Authors:  Anastasios D Giannou; Antonia Marazioti; Magda Spella; Nikolaos I Kanellakis; Hara Apostolopoulou; Ioannis Psallidas; Zeljko M Prijovich; Malamati Vreka; Dimitra E Zazara; Ioannis Lilis; Vassilios Papaleonidopoulos; Chrysoula A Kairi; Alexandra L Patmanidi; Ioanna Giopanou; Nikolitsa Spiropoulou; Vaggelis Harokopos; Vassilis Aidinis; Dionisios Spyratos; Stamatia Teliousi; Helen Papadaki; Stavros Taraviras; Linda A Snyder; Oliver Eickelberg; Dimitrios Kardamakis; Yoichiro Iwakura; Thorsten B Feyerabend; Hans-Reimer Rodewald; Ioannis Kalomenidis; Timothy S Blackwell; Theodora Agalioti; Georgios T Stathopoulos
Journal:  J Clin Invest       Date:  2015-04-27       Impact factor: 14.808

Review 9.  Malignant pleural effusion management: keeping the flood gates shut.

Authors:  Steven Walker; Rachel Mercer; Nick Maskell; Najib M Rahman
Journal:  Lancet Respir Med       Date:  2019-10-25       Impact factor: 30.700

10.  Impaired T cell function in malignant pleural effusion is caused by TGF-β derived predominantly from macrophages.

Authors:  Lifeng Li; Li Yang; Liping Wang; Fei Wang; Zhen Zhang; Jieyao Li; Dongli Yue; Xinfeng Chen; Yu Ping; Lan Huang; Bin Zhang; Yi Zhang
Journal:  Int J Cancer       Date:  2016-08-06       Impact factor: 7.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.